Late-Breaking Clinical Trials Scheduled for Release at Heart Rhythm Society’s 35th Annual Scientific Sessions

Eighteen late-breaking clinical trials to be presented at Heart Rhythm 2014

May 08, 2014

Media Contact

Ken Demith
Heart Rhythm Society

SAN FRANCISCO, May 8, 2014 – Late-Breaking Clinical Trials will be revealed at Heart Rhythm 2014, the Heart Rhythm Society’s 35th Annual Scientific Sessions.

Session I: Thursday, May 8, 2014, 1:30 p.m. – 3:00 p.m. PDT in Room 305, Moscone South

Embargo Time: Thursday, May 8 at 1:30 p.m. PDT

  • Shockless Implant Evaluation (SIMPLE): A Randomized Trial of Routine Defibrillation Testing, Compared to No Testing, at Time of Defibrillator Implantation
  • Adenosine-guided pulmonary vein isolation for the treatment of atrial fibrillation: Results of the prospective multicenter randomized ADVICE trial
  • Ablation of Clinical Stable Ventricular Tachycardia Versus Substrate Base Ablation on long term freedom from any VT: Results from a randomized multicenter study VISTA
  • Prophylactic Pulmonary Vein Isolation During Isthmus Ablation for Atrial Flutter. The PReVENT AF Study I
  • Increased Adherence to Remote Monitoring is Associated with Reduced Mortality in Both Pacemaker and Defibrillator Patients
  • Dual-targeted Thoracic Spinal Cord Stimulation for Heart Failure as a Restorative Treatment (SCS HEART): First-in man Experience
Session II: Friday, May 9, 2014, 8:00 a.m. – 9:30 a.m. PDT in Room 305, Moscone South

Embargo Time: Friday, May 9 at 8:00 a.m. PDT

  • Chronic Performance of Leadless Cardiac Pacing: One Year Follow-up to the LEADLESS Trial
  • Botulinum Toxin Injection in Epicardial Fat Pads Can Prevent Recurrences of Atrial Fibrillation After Cardiac Surgery: Results of a Randomized Pilot Study
  • Atrial Fibrillation Patients with Contraindications to Oral Anticoagulation Therapy Treated with LAA Ligation: Initial Long-term Clinical Outcomes
  • Baseline Characteristics, Outcomes, and Comparison of Edoxaban vs Warfarin by AF Subtype in 21,105 Patients Enrolled in the ENGAGE AF-TIMI 48 Trial
  • Safety and Efficacy of Left Ventricular Endocardial Lead Pacing for Cardiac Resynchronization Therapy: Primary Results of the ALternate Site Cardiac ResYNChronization (ALSYNC) Study
  • Point by point radiofrequency ablation versus the cryoballoon or a novel combined approach: a randomized trial comparing three methods of pulmonary vein isolation for paroxysmal atrial fibrillation (The Cryo versus RF trial)
Session III: Saturday, May 10, 2014, 10:30 a.m. – 12:00 p.m. PDT in Room 2004, Moscone West

Embargo Time: Saturday, May 10 at 10:30 a.m. PDT

  • Is it Safe to Delay Detection in All ICD patients? A Randomized Evaluation of Prolonged ICD Detection Intervals in Secondary Prevention Patients enrolled in the PainFree SST Trial
  • SPEAR Trial: Smartphone Pediatric ElectrocARdiogram Trial
  • Use of Remote Monitoring is Associated with Improved Outcomes Among Patients with Implantable Cardioverter Defibrillators
  • RAFFAELLO (Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion)
  • The Effect of the Combination of Ranolazine and Low Dose Dronedarone on Atrial Fibrillation Burden in Patients with Paroxysmal Atrial Fibrillation (HARMONY Trial)
  • The Effects of Reactive Atrial Antitachycardia Pacing on the Progression of Atrial Tachyarrhythmias: Results of the Randomized MINERVA Trial

Press briefings featuring several Late-Breaking Clinical Trials will be held at 11:00 a.m. PDT on Thursday, May 8 and at 7:00 a.m. PDT on Friday, May 9. These briefings will be held in the Scientific Sessions’ press briefing room (Room 224) at the Moscone Center.

More information on Late-Breaking Clinical Trials will be available at Heart Rhythm 2014.

Sessions details:

“Late-Breaking Clinical Trials Session I” [May 8, 2014, 1:30 p.m.–3:00 p.m. PDT, Room 305, Moscone South]

“Late-Breaking Clinical Trials Session II” [May 9, 2014, 8:00 a.m. – 9:30 a.m. PDT, Room 305, Moscone South]

“Late-Breaking Clinical Trials Session III” [May 10, 2014, 10:30 a.m.–12:00 p.m. PDT, Room 2004, Moscone West]

Heart Rhythm 2014 brings together the world’s most noted experts and features more than 8,500 attendees, 250 educational sessions and more than 900 exhibitors showcasing innovative products and services. It is an opportunity for the global heart rhythm community to explore the ideas, people and technology that are advancing the electrophysiology (EP) field.

About the Heart Rhythm Society

The Heart Rhythm Society is the international leader in science, education, and advocacy for cardiac arrhythmia professionals and patients, and the primary information resource on heart rhythm disorders. Its mission is to improve the care of patients by promoting research, education, and optimal health care policies and standards. Incorporated in 1979 and based in Washington, DC, it has a membership of more than 6,000 heart rhythm professionals in more than 72 countries around the world. For more information, visit